80,400.00
+1,300.00
+(1.64%)
At close: January 31 at 3:30:15 PM GMT+9
Breakdown
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Total Assets
751,721,630.09
967,265,434.79
743,692,264.09
706,477,276.99
Total Liabilities Net Minority Interest
169,475,199.91
268,287,104.47
231,507,461.39
149,047,858.40
Total Equity Gross Minority Interest
582,246,430.18
698,978,330.32
512,184,802.69
557,429,418.59
Total Capitalization
541,818,761.07
638,257,266.40
483,335,208.66
480,365,324.00
Preferred Stock Equity
3,708.00
3,594.00
3,594.00
1,829.00
Common Stock Equity
523,881,833.07
637,933,672.40
435,953,756.66
479,749,501.00
Capital Lease Obligations
16,025,380.25
14,338,469.25
10,953,728.00
10,392,953.00
Net Tangible Assets
254,848,096.07
293,159,211.40
96,421,248.66
215,906,114.00
Working Capital
58,074,408.81
143,244,937.47
66,322,486.24
153,545,797.34
Invested Capital
570,518,457.07
753,440,987.40
504,548,526.66
524,355,783.00
Tangible Book Value
254,844,388.07
293,155,617.40
96,417,654.66
215,904,285.00
Total Debt
62,662,004.25
129,845,784.25
79,548,498.00
54,999,235.00
Share Issued
130,134.91
122,289.18
120,578.25
119,841.73
Ordinary Shares Number
129,874.24
122,148.62
120,426.83
119,538.91
Preferred Shares Number
4.77
7.06
7.06
3.53
Treasury Shares Number
260.67
140.57
151.41
302.83
12/31/2020 - 12/24/2008
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
115450.KQ HLB Therapeutics Co.,Ltd.
11,410.00
+0.62%
298380.KQ ABL Bio Inc.
36,350.00
+2.97%
RGRX RegeneRx Biopharmaceuticals, Inc.
0.0014
0.00%
TYRA Tyra Biosciences, Inc.
14.46
-1.70%
SNPX Synaptogenix, Inc.
3.4300
+1.78%
PMVP PMV Pharmaceuticals, Inc.
1.4200
-1.39%
1177.HK SINO BIOPHARM
2.820
-3.75%
LYEL Lyell Immunopharma, Inc.
0.5903
+1.22%
SNGX Soligenix, Inc.
2.3300
+0.87%
NUVB Nuvation Bio Inc.
2.3100
-3.75%